Speakers:

Dominic Muyldermans

Senior Legal Advisor
ABS International (Belgium)

Tom Leonard

Partner
Kilburn & Strode (United Kingdom)

Katie Beckett

ABS Project Manager
Department for Business Innovation and Skills (UK)

Doris Schernhammer

Senior Manager for Corporate Affairs
Eli Lilly (Belgium)

Stephen Inglis

Director
National Institute for Biological Standards & Control (United Kingdom)

Philippe de Jong

Partner
Altius (Belgium)

John Schmidt

Partner
Shepherd and Wedderburn

Gavin Lawson

Senior Litigation Counsel
GILEAD (United Kingdom)

Elisabeth Greiner

Partner
df-mp (Germany)

Juergen Dressel

Head of Global Patent Litigation Strategy
Novartis (Switzerland)

Rana Gosain

Partner
Daniel Advogados (Brazil)

Brazil – Where Are We Now?

October 21, 2016 2:00 pm

Toshio Nakamura

Partner
Sakamoto & Partners (Japan)

Oliver Lutze

Partner
Spruson & Ferguson (China)

Pharmaceutical Patents in China

October 21, 2016 11:30 am

Pierre Véron

Véron & Associés, Paris Honorary President
EPLAW (European Patent Lawyers Association) Member of the Expert Panel group of the Unified Patent Court Member of the Drafting Committee of the Rules of Procedure

Christoph Rehfuess

Head of IP
Sotio

Gualtiero Dragotti

Partner
DLA Piper

Sam Granata

Judge
Antwerp Court of Appeal (Belgium)

Brian Coggio

Partner
Fish & Richardson (United States)

David Wilson

Partner
Carpmaels & Ransford

Rob Aerts (Spain)

Director IP
Tigenix SAU, Tres Cantos – Madrid, Spain

Gabriel Cuonzo

Partner
Trevisan & Cuonzo

Matthias Scholz

Partner
Baker & McKenzie (Germany)

Elise Melon

Director of the Intellectual Property Policy
European Federation of Pharmaceutical Industries and Associations

Alexandre Entraygues

Head Data Privacy
Novartis

Bettina Wanner

Head of IP Advocacy
Bayer Intellectual Property GmbH (Germany)

Hari Subramaniam

Partner
Subramaniam & Associates (India)

Gunars Gaikis

Partner
Smart & Biggar (Canada)

Ha Kung Wong

Partner
Fitzpatrick, Cella, Harper & Scinto (United States)

Scott Reed

Partner
Fitzpatrick, Cella, Harper & Scinto (United States)

Paul Reeskamp

Partner
DLA Piper (Netherlands)

Is There Life (Sciences) After Brexit?

October 20, 2016 12:00 pm

Christoph de Costa

Partner
Taylor Wessing (Germany)

James Horgan

Assistant Managing Counsel
Merck Sharpe & Dohme (UK)

Is There Life (Sciences) After Brexit?

October 20, 2016 12:00 pm

Dr. Peter Feldschreiber

Counsel
Four New Square (United Kingdom)

Is There Life (Sciences) After Brexit?

October 20, 2016 12:00 pm

Bonella Ramsay

Partner
DLA Piper (United Kingdom)

Is There Life (Sciences) After Brexit?

October 20, 2016 12:00 pm

Nicola Dagg

Partner
Allen & Overy (United Kingdom)

Ian Hiscock

Head IP Oncology
Novartis (United Kingdom)

Timo Minssen

Professor of Biotechnology Law, Jur. Dr., LL.M., M.I.C.L.
Centre for Information and Innovation Law (CIIR) (Germany)

Oliver Werner

Head SPC Working Group
German Patent and Trademark Office (Germany)

Matthew Royle

Partner
Taylor Wessing

Ben Goldacre (United Kingdom)

Early Publishing of Clinical Trial Data

October 20, 2016 9:15 am

Simon Bradbury

Head of Life Sciences
Appleyard Lees (United Kingdom)

Georg Rauh

Partner
Vossius & Partners (Germany)

Louise Jonshammar

Attorney at Law
IAM Advokatbyrå (Sweden)

Dieter Tzschoppe

Director
European Patent Office (Germany)

Hilary van der Hoff

Director
Kymab (UK)

Natalie Voruz

Assistant General Counsel
Monsanto (Switzerland)

Eugenia Garrett-Wackowski

Partner
Kilpatrick Townsend & Stockton (USA)

Roberto Valenti

Partner
DLA Piper (Italy)

Opening Remarks from the Chair

October 21, 2016 8:55 am